Iveric Bio Inc (ISEE) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iveric Bio Inc   (NASDAQ: ISEE)


Iveric Bio Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iveric Bio Inc's ROI in the first quarter of 2023?
Iveric Bio Inc recorded a cumulative net loss of $-223 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -49.38%.

Within the Healthcare sector 631 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 4141 to 4493.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM 69.92 % 74.61 % 78.18 % 70.16 % 30.93 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 574 631 307 293 334
Return On Investment (TTM) -49.38 % -47.33 % -49.16 % -46.53 % -46.02 %
ISEE's Overall Ranking # 4493 # 4141 # 0 # 0 # 0
Seq. Investment Change TTM 15.36 % 20.85 % 6.57 % 14.36 % 18.55 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -223 -185 -159 -141 -122

ISEE Company Profile >> Back to ISEE Roi Comparisons >> See Annual ISEE Return On Investment



Return On Investment ISEE's Ranking
Within: No.
Industry # 270
Sector # 632
Overall # 4493

Return On Investment Statistics
High Average Low
145 %
-11.01 %
-85.72 %
(Dec 31 2013)   (Jun 30 2017)







Financial Statements
Iveric Bio Inc's I. Quarter Investments $ 574 Millions ISEE's Balance sheet
Iveric Bio Inc's I. Quarter Income $ -72 Millions Quarterly ISEE's Income Statement
ISEE's Income by Division See ISEE's Income by Division


ISEE Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 631 361 192 117 124
Y / Y Investment Growth 74.79 % 88.47 % 63.5 % -5.45 % -23.97 %
Net Income in Millions -185 -115 -85 -59 63
Y / Y Net Income Growth - - - - -44.76 %
Annual Return On Investment -29.34 % -31.71 % -44.12 % -50.22 % 50.89 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ISEE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ISEE's Competitors
Subscribers only: Roi for Iveric Bio Inc's Suppliers
Subscribers only: Return On Investment for ISEE's Customers

Other Ratios
ISEE's Roa ISEE's Inventory Turnover Ratio ISEE's Growth Rates ISEE's Dividend Statistics
ISEE's Profitability Ratios ISEE's Asset Turnover Ratio ISEE's Dividend Growth
ISEE's Roe ISEE's Valuation Ratios ISEE's Financial Strength Ratios ISEE's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.